Abstract
Background: Type 1 diabetes is a chronic autoimmune disease featured by insulin deprivation caused by pancreatic β-cell loss, followed by hyperglycaemia.
Objective: Currently, there is no cure for this disease in clinical treatment, and patients have to accept a lifelong injection of insulin. The exploration of potential diagnosis biomarkers through analysis of mass data by bioinformatics tools and machine learning is important for type 1 diabetes.
Methods: We collected two mRNA expression datasets of type 1 diabetes peripheral blood samples from GEO, screened differentially expressed genes (DEGs) by R software, and conducted GO and KEGG pathway enrichment using the DEGs. Moreover, the STRING database and Cytoscape were used to build PPI network and predict hub genes. We constructed a logistic regression model by using the hub genes to assess sample type.
Results: Bioinformatic analysis of the GEO dataset revealed 92 and 75 DEGs in GSE50098 and GSE9006 datasets, separately, and 10 overlapping DEGs. PPI network of these 10 DEGs showed 7 hub genes, namely EGR1, LTF, CXCL1, TNFAIP6, PGLYRP1, CHI3L1 and CAMP. We built a logistic regression model based on these hub genes and optimized the model to 3 genes (LTF, CAMP and PGLYRP1) based logistic model. The values of the area under the curve (AUC) of training set GSE50098 and testing set GSE9006 were 0.8452 and 0.8083, indicating the efficacy of this model.
Conclusion: Integrated bioinformatic analysis of gene expression in type 1 diabetes and the effective logistic regression model built in our study may provide promising diagnostic methods for type 1 diabetes.
Keywords: Type 1 diabetes, bioinformatic analysis, logistic regression model, diagnosis, GO, KEGG.
Current Pharmaceutical Design
Title:A Three-gene-based Type 1 Diabetes Diagnostic Signature
Volume: 27 Issue: 24
Author(s): Rongrong Wang, Yanan Zhou, Yan Zhang, Shaoqing Li, Runzhou Pan and Yongcai Zhao*
Affiliation:
- Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000,China
Keywords: Type 1 diabetes, bioinformatic analysis, logistic regression model, diagnosis, GO, KEGG.
Abstract:
Background: Type 1 diabetes is a chronic autoimmune disease featured by insulin deprivation caused by pancreatic β-cell loss, followed by hyperglycaemia.
Objective: Currently, there is no cure for this disease in clinical treatment, and patients have to accept a lifelong injection of insulin. The exploration of potential diagnosis biomarkers through analysis of mass data by bioinformatics tools and machine learning is important for type 1 diabetes.
Methods: We collected two mRNA expression datasets of type 1 diabetes peripheral blood samples from GEO, screened differentially expressed genes (DEGs) by R software, and conducted GO and KEGG pathway enrichment using the DEGs. Moreover, the STRING database and Cytoscape were used to build PPI network and predict hub genes. We constructed a logistic regression model by using the hub genes to assess sample type.
Results: Bioinformatic analysis of the GEO dataset revealed 92 and 75 DEGs in GSE50098 and GSE9006 datasets, separately, and 10 overlapping DEGs. PPI network of these 10 DEGs showed 7 hub genes, namely EGR1, LTF, CXCL1, TNFAIP6, PGLYRP1, CHI3L1 and CAMP. We built a logistic regression model based on these hub genes and optimized the model to 3 genes (LTF, CAMP and PGLYRP1) based logistic model. The values of the area under the curve (AUC) of training set GSE50098 and testing set GSE9006 were 0.8452 and 0.8083, indicating the efficacy of this model.
Conclusion: Integrated bioinformatic analysis of gene expression in type 1 diabetes and the effective logistic regression model built in our study may provide promising diagnostic methods for type 1 diabetes.
Export Options
About this article
Cite this article as:
Wang Rongrong , Zhou Yanan, Zhang Yan , Li Shaoqing, Pan Runzhou and Zhao Yongcai *, A Three-gene-based Type 1 Diabetes Diagnostic Signature, Current Pharmaceutical Design 2021; 27 (24) . https://dx.doi.org/10.2174/1381612826666201217143403
DOI https://dx.doi.org/10.2174/1381612826666201217143403 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug-Drug Interactions Associated with Antiplatelet Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms
Cardiovascular & Hematological Disorders-Drug Targets D-amino Acids as Novel Blood-based Biomarkers
Current Medicinal Chemistry Preface [Hot Topic: The Roller Coaster of Antioxidant Therapy (Guest Editor: Francesco Visioli)]
Current Medicinal Chemistry HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Hematopoietic Colony Stimulating Factors in Cardiovascular and Pulmonary Remodeling: Promoters or Inhibitors?
Current Pharmaceutical Design CPR Education
Current Pediatric Reviews Teenage-Pregnancies - A Biomedical and a Sociocultural Approach to a Current Problem
Current Women`s Health Reviews Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online (Discontinued) Meet The Guest Editor
Combinatorial Chemistry & High Throughput Screening Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development
CNS & Neurological Disorders - Drug Targets Neurotransmission Alterations in Central Cardiovascular Control in Experimental Hypertension
Current Hypertension Reviews Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Current Drug Targets Management of Obesity
Current Respiratory Medicine Reviews Effect of Antioxidant Extract from Cherries on Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Melatonin and Related Compounds: Chemical Insights into their Protective Effects Against Oxidative Stress
Current Organic Chemistry Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Current Alzheimer Research Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Current Pharmaceutical Design